Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nikolitsa Kafasi
Observed names:
N Kafasi,
N. Kafasi
Institution:
Laiko General Hospital of Athens
Observed institutions:
National and Kapodistrian University of Athens,
Laiko General Hospital of Athens,
Evangelismos Hospital
ORCID:
0000-0003-3518-1705
Observed ORCID:
0000-0003-3518-1705
OpenAlex ID:
A5017828285
Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome
2020
·
Harry Alexopoulos
, Eleni Magira
, et al.
·
Neurology Neuroimmunology & Neuroinflammation
·
131
PDF
Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus
2007
·
A. Kasparian
, A. Floros
, et al.
·
Lupus
·
54
Ratio of involved/uninvolved immunoglobulin quantification by Hevylite™ assay: clinical and prognostic impact in multiple myeloma
2012
·
Efstathios Koulieris
, Panayiotis Panayiotidis
, et al.
·
Experimental Hematology and Oncology
·
43
PDF
Infliximab treatment-induced formation of autoantibodies is common in Behçet's disease.
2008
·
A Elezoglou
, N Kafasi
, et al.
·
PubMed
·
30
Endothelial progenitor cells and peripheral neuropathy in subjects with type 2 diabetes mellitus
2020
·
Ioanna Eleftheriadou
, Natalia Dimitrakopoulou
, et al.
·
Journal of Diabetes and its Complications
·
15
Diagnostic role of cytology in serous effusions of patients with hematologic malignancies
2018
·
Kyriaki Savvidou
, Aglaia Dimitrakopoulou
, et al.
·
Diagnostic Cytopathology
·
15
Monomorphic epitheliotropic intestinal T‐cell lymphoma in pleural effusion: A case report
2017
·
F. Antoniadou
, A. Dimitrakopoulou
, et al.
·
Diagnostic Cytopathology
·
12
Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia
2013
·
Katerina Sarris
, Dimitrios Maltezas
, et al.
·
Advances in Hematology
·
9
PDF
Serum-Soluble CD163 Levels as a Prognostic Biomarker in Patients with Diffuse Large B-Cell Lymphoma Treated with Chemoimmunotherapy
2024
·
Marie-Christine Kyrtsonis
, Aspasia Koudouna
, et al.
·
International Journal of Molecular Sciences
·
6
PDF
IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients
2021
·
Aigli G. Vakrakou
, Dimitrios Tzanetakos
, et al.
·
Journal of Neuroimmunology
·
6
Tumor-Associated Macrophage (TAM)-Related Cytokines, sCD163, CCL2, and CCL4, as Novel Biomarkers for Overall Survival and Time to Treatment in Waldenstrom’s Macroglobulinemia: Emphasis on Asymptomatic WM
2025
·
Alexandros Gkiokas
, Mavra Papadatou-Gigante
, et al.
·
Cells
·
4
PDF
The Addition of sFLCR Improves ISS Prognostication in Multiple Myeloma (MM).
2007
·
Marie-Christine Kyrtsonis
, Theodoros P. Vassilakopoulos
, et al.
·
Blood
·
3
Impact of Novel M-Component Based Biomarkers On to Progression Free Survival After Treatment in Intact Immunoglobulin Multiple Myeloma.
2012
·
Efstathios Koulieris
, Dimitrios Maltezas
, et al.
·
Blood
·
1
Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia (cll) Prognosis
2012
·
Katerina Sarris
, Vassiliki Bartzis
, et al.
·
Blood
·
1
Prevalence of Antiphospholipid Antibodies in Greek Individuals with Type 1 Diabetes and Their Association with Diabetes-Related Complications
2026
·
Stavroula-Panagiota Lontou
, Ioanna A. Anastasiou
, et al.
·
Diabetology
P-169 Tumor Associated Macrophages’ cytokines; CD163, CCL4 and CCL2, as Possible New Biomarkers for Overall Survival and Transformation in Smoldering Multiple Myeloma
2024
·
Alexandros Gkiokas
, Annita-Ioanna Gkioka
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Soluble CD163; A Possible New Biomarker in Multiple Myeloma
2023
·
Annita Ioanna Gkioka
, Alexandros Gkiokas
, et al.
·
Blood
Aberrant Immunoglobulin Variations as Indicators of Eventual Clonal Changes in Symptomatic Multiple Myeloma Patients' Course
2014
·
Eftychia Nikolaou
, Efstathios Koulieris
, et al.
·
Current Cancer Therapy Reviews
Evaluation Of Immunoglobulin Variations (Clonal Changes) In Symptomatic Multiple Myeloma (MM) Patients’ Course
2013
·
Eftychia Nikolaou
, Panayiotis Panayiotidis
, et al.
·
Blood
A Shorter Time to First Treatment and Worst Overall survival Is Observed in Cll Patients with Reduced Serum IgM As Evaluated with Novel Serum Immunoassays
2012
·
Efstathios Koulieris
, Katerina Sarris
, et al.
·
Blood
A436 Role of Soluble Syndecan-1 in FLC Hypersecretion in MM
2009
·
D Maltezas
, P Repousis
, et al.
·
Clinical Lymphoma & Myeloma
Show more works
View as search
Works count:
22
Citation count:
330
H-index:
8
I10-index:
7
Year
Topic
Type
